AHA to CMS: Withdraw proposed 340B cut

AHA News

The Centers for Medicare & Medicaid Services (CMS) should withdraw its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program, AHA yesterday told the agency in comments on its outpatient prospective payment system proposed rule for calendar year 2018.

“CMS... read more

Topic: Advocacy and Public Policy
Tags: 340B, Medicare, regulation, administrative simplification

AHA convenes Capitol Hill forum on rural hospital priorities

AHA News

Rural hospital and health system leaders today received an update on their legislative and policy priorities at an AHA Rural Hospital Policy Forum before meeting with their representatives on Capitol Hill.

Sen. Chuck Grassley (R-IA), lead sponsor of the AHA-supported Rural Emergency Acute Care Hospital... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: 340B, rural, access

CMS releases 2018 outpatient PPS and physician payment proposed rules

AHA News

The AHA July 13 criticized proposed deep cuts to how much the Centers for Medicare & Medicaid Services reimburses hospitals for drugs acquired under the 340B Drug Pricing Program and proposes changes to site-neutral payment policies under Section 603 of the 2015 Bipartisan Budget Act. The provisions are... read more

Topics: Quality and Patient Safety, Advocacy and Public Policy
Tags: 340B, site neutral payment, Drug Pricing Program, Medicare, regulation

AHA critical of MedPAC's "misdirected" 340B payment proposal

AHA News

The AHA last week criticized as “misdirected” and a blow to patient care the Medicare Payment Assessment Commission’s (MedPAC) recommendation that Congress reduce Part B drug payment rates to hospitals participating in the 340B Drug Pricing Program.

At its Jan. 14 meeting, the commission voted 14 to 3 to... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program

Amid concerns of possible policy changes, hospitals brief Congress on 340B's benefits

AHA News

At an AHA-sponsored briefing Nov. 19 on Capitol Hill, hospital leaders urged Congress to protect the 340B Drug Pricing Program, and shared with congressional staff the benefits that the program brings to vulnerable patients.

“People within the communities that Trinity Health serves receive tremendous and... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, access

AHA: Proposed 340B guidance would hurt hospitals' ability to serve patients

AHA News

The Health Resources and Services Administration’s (HRSA) proposed omnibus guidance for the 340B Drug Pricing Program would jeopardize hospitals’ ability to serve vulnerable populations, including low-income and uninsured individuals and patients receiving cancer treatments, AHA told the agency in ... read more

Topic: Advocacy and Public Policy
Tag: 340B

Court ruling on 340B drug case draws AHA's ire

AHA News

The AHA last week said it is “very disappointed” with a federal court decision that will exclude all drugs with an “orphan” designation from the 340B Drug Pricing Program for rural and cancer hospitals.

Denying rural and cancer hospitals access to these 340B discounts will “reduce access to critical... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: 340B, access

AHA disappointed with court's ruling in 340B orphan drug case

AHA News

The AHA today expressed disappointment with a federal court decision that will exclude all drugs with an “orphan” designation from the 340B Drug Pricing Program for rural and cancer hospitals.

 AHA Executive Vice President Tom Nickels said in a statement that denying rural and cancer hospitals access to... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program

Hospital leaders tell their story about 340 B program

AHA News

Congress should preserve the 340B Drug Pricing Program because of the many benefits to low-income and uninsured patients, the AHA said today in a statement submitted to the House Energy and Commerce Health Subcommittee. As part of its advocacy efforts on behalf of the 340B program, the AHA has released... read more

Topic: Advocacy and Public Policy
Tag: 340B

AHA urges Congress to maintain support for 340B program

AHA News

Congress should preserve the 340B Drug Pricing Program because of the many benefits to low-income and uninsured patients, the AHA said today in a statement submitted to the House Energy and Commerce Health Subcommittee.

In a statement submitted to the committee for a hearing examining the 340B program,... read more

Topic: Advocacy and Public Policy
Tags: 340B, access

Keyword Search

Date